CUSABIO Antibodies against Rare Species of Uncommon Bacteria

In life science and biomedicine, uncommon bacteria such as Proteobacteria, Firmicutes, and Streptococcus are vital pathogens. Their diverse traits make them central to medical microbiology and clinical infection control. Proteobacteria, like Pseudomonas aeruginosa, aid in studying bacterial adaptation and antibiotic resistance. Firmicutes, including Listeria, help unravel survival in extreme environments and chronic infections. Streptococcus, represented by S. pneumoniae, offers insights into pathogenicity and vaccine development.These bacteria are crucial for analyzing biofilms, tracing drug resistance, and developing new antibacterial methods. Their unique features, like Proteobacteria's secretion system and Streptococcus' M proteins, underpin clinical medicine and public health advances. With new technologies, they promise broader applications in microbiome management and early resistance warning.

CUSABIO's Rare Species Antibody Series provides specific antibodies for uncommon bacteria, targeting key epitopes to meet needs in virulence monitoring, biofilm analysis, and multi-pathogen detection.